jcm-logo

Journal Browser

Journal Browser

Hemophilia: Current Trends and Future Directions

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".

Deadline for manuscript submissions: 20 September 2025 | Viewed by 668

Special Issue Editors


E-Mail Website
Guest Editor
1. Bleeding & Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI, Peoria, IL, USA
2. Departments of Pediatrics and Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA
Interests: hemophilia; Von Willebrand disease; coagulation laboratory testing; hemostasis; thrombosis; platelet disorders; pa-tient-centered outcome measures; anticoagulation

E-Mail Website
Guest Editor
Sol Price School of Public Policy, University of Southern California, Los Angeles, CA 90089, USA
Interests: hemophilia; prophylaxis; gene therapy; burden of illness; quality of life; patient-reported outcomes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Hemophilia diagnosis and treatment have evolved significantly in the recent twenty years. Increasing attention is being paid to the burden of illness, quality of life, and treatment preferences for individuals with this disorder. While principal outcomes frequently measure bleeds, joint arthropathy, and pain, other quality-of-life considerations may be important to patients. Most importantly, there is recognition that this disorder affects individuals across the globe, including women who have been under-recognized with hemophilia. Moreover, international efforts have advocated for broader treatment and treatment options.

With the development of a variety of new treatments, it is essential to develop and assess research on treatment outcomes. In addition to clinical trials, observational studies can provide insights into treatment effects and predictors of success. The focus of this Special Issue is to report on new areas of treatment, new measurements being used to identify treatment effects, and treatment outcomes. This Issue will also consider the potential impacts of treatments presently under development and how clinicians may adopt them.

Dr. Jonathan C. Roberts
Dr. Michael B. Nichol
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hemophilia
  • prophylaxis
  • gene therapy
  • burden of illness
  • quality of life
  • patient reported outcomes
  • hemarthrosis
  • women and hemophilia

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 825 KiB  
Review
Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus
by Rubén Berrueco, Inmaculada Soto, José María Bastida, José Manuel Calvo Villas, Carmen de Cos, Saturnino Haya, Francisco Sierra García and José Mateo Arranz
J. Clin. Med. 2025, 14(10), 3300; https://doi.org/10.3390/jcm14103300 - 9 May 2025
Viewed by 263
Abstract
Background/Objectives: For people with haemophilia, health-related quality of life mainly depends on the arthropathy caused by repeated joint bleeding. Prophylaxis is the standard of care in patients with severe bleeding phenotypes, but globally, none of the measures used to assess patients’ outcomes [...] Read more.
Background/Objectives: For people with haemophilia, health-related quality of life mainly depends on the arthropathy caused by repeated joint bleeding. Prophylaxis is the standard of care in patients with severe bleeding phenotypes, but globally, none of the measures used to assess patients’ outcomes consider their desires and life expectations. We propose the concept of the “patient-centred management of well-controlled haemophilia” to define individual responses to prophylaxis. The aims of this work are (1) to achieve agreement about the definition of the “patient-centred management of well-controlled haemophilia” by a steering committee of experts, and (2) to share a series of statements that should define the “patient-centred management of well-controlled haemophilia” with other haemophilia clinicians looking for a consensus in this scenario. Methods: An eight-expert group was established to define the concept of the “patient-centred management of well-controlled haemophilia”. Seven major aspects were identified, and a final version of 42 statements was established and distributed to a 75-expert panel for consensus gathering using the Delphi methodology. Results: Forty-eight experts participated in the first round (participation rate: 64%); two sentences from domain 3 were split, leading to a total of 44 statements across the seven domains. Consensus was achieved in 92.85% of cases. Five items and three statements advanced to the second round. Eleven statements were reconsidered in the second round (response rate: 100%). The questionnaire presented high internal consistency. Conclusions: New treatments offer promising solutions for patients, but there is a paucity of models to measure global outcomes. Patient-centred medicine requires multidimensional assessment, and the “patient-centred management of well-controlled haemophilia” concept is intended to enable this. Full article
(This article belongs to the Special Issue Hemophilia: Current Trends and Future Directions)
Show Figures

Figure 1

Back to TopTop